ACPU
ELV icon

Arrowgrass Capital Partners (US)’s Elevance Health ELV Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-90,851
Closed -$9.04M – 245
2014
Q1 		$9.04M Buy
+90,851
New +$8.22M 0.36% 62

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Arrowgrass Capital Partners (US)'s ELV Position: Q2 2014 in Review

Arrowgrass Capital Partners (US) sold out of Elevance Health (ELV) in Q2 2014, closing a stake of 90,851 shares — an estimated $9.04M sold.

Arrowgrass Capital Partners (US) first reported a position in ELV in Q1 2014 and held it in 1 quarter. The position peaked at $9.04M in Q1 2014. 687 funds tracked by Wall St. Rank hold ELV as of Q2 2014.

  • Arrowgrass Capital Partners (US) reported no remaining Elevance Health position as of Q2 2014 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 90,851 Elevance Health shares in Q2 2014, an estimated $9.04M.
  • Arrowgrass Capital Partners (US) first reported a position in Elevance Health in Q1 2014 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Elevance Health position peaked at $9.04M in Q1 2014.
  • 687 funds tracked by Wall St. Rank held Elevance Health as of Q2 2014.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2014, filed 14 Aug 2014.